The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study.
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Gilead Sciences; Gilead Sciences; Lilly; Merck; Roche/Genentech; Sanofi/Aventis
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Stéphane Cattan
Leadership - AstraZeneca; Ipsen; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Roche
 
Philippe Merle
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Ipsen; Lilly; MSD; Roche
Research Funding - Ipsen
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Bruno Daniele
Honoraria - AstraZeneca; Bayer; Eisai; Ipsen; Lilly; MSD; Roche
Consulting or Advisory Role - Eisai; Ipsen; MSD; Roche; Sanofi
 
Stephen Lam Chan
Consulting or Advisory Role - AstraZeneca/MedImmune; MSD Oncology; Novartis
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
Mohamed Bouattour
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche; Sirtex Medical
Travel, Accommodations, Expenses - Bayer; Roche
 
Ho Yeong Lim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bayer
 
Yee Chao
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Sadahisa Ogasawara
Honoraria - Bayer; Eisai; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly; Merck
Research Funding - Bayer; Eisai; Lilly
 
Marcelo Garrido
Consulting or Advisory Role - MSD; Novartis
Speakers' Bureau - Bayer; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; F. Hoffmann LaRoche; Ipsen; IQVIA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; F. Hoffmann LaRoche; Ipsen; IQVIA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Roche/Genentech
Speakers' Bureau - Amgen; Bayer Yakuhin; Eisai; Novartis; Ono Pharmaceutical
Travel, Accommodations, Expenses - Bayer Yakuhin; IQVIA; Roche/Genentech
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Ipsen; MSD; Roche
Research Funding - Beigene (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Expert Testimony - Bayer
 
Abby B. Siegel
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ahmadur Rahman
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Chih-Chin Liu
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)